Comparison of the hepatic metabolism of triazolam in wild-type andCyp3a-knockout mice for understanding CYP3A-mediated metabolism inCYP3A-humanised mice in vivo
1. To investigate cytochrome P450 3A (CYP3A)-mediated metabolism in vivo, plasma concentrations of triazolam (TRZ) are often monitored as a CYP3A marker in CYP3A-humanised mice. However, it has not been determined whether plasma concentrations of TRZ after intravenous administration can reflect hepatic CYP3A activity in CYP3A-humanised mice. 2. Firstly, we investigated the pharmacokinetics of TRZ in wild-type and Cyp3a-knockout (Cyp3a-KO) mice. Plasma concentration profiles of TRZ and α-hydroxy (OH) TRZ were very similar in wild-type and Cyp3a-KO mice. On the other hand, AUC of 4-OH TRZ in Cyp3a-KO mice was significantly lower than that in wild-type mice. Pregnenolone 16α-carbonitrile (PCN) decreased the areas under the plasma concentration-time curves (AUCs) of TRZ and α-OH TRZ in both groups. There was no significant effect of PCN on AUC of 4-OH TRZ in Cyp3a-KO mice. 3. Next, we verified that AUC of 4-OH TRZ in CYP3A-humanised mice was higher than that in Cyp3a-KO mice, although the difference was not significant. 4. In conclusion, plasma concentrations of 4-OH TRZ, but not those of TRZ and α-OH TRZ, might reflect hepatic CYP3A activity in mice in vivo. These results provide important insights for in vivo studies using a CYP3A-humanised model.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
Xenobiotica; the fate of foreign compounds in biological systems - 49(2019), 11 vom: 17. Nov., Seite 1303-1310 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Minegishi, Genki [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 05.02.2020 Date Revised 05.02.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/00498254.2018.1560516 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM291910181 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM291910181 | ||
003 | DE-627 | ||
005 | 20231225071922.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/00498254.2018.1560516 |2 doi | |
028 | 5 | 2 | |a pubmed24n0973.xml |
035 | |a (DE-627)NLM291910181 | ||
035 | |a (NLM)30561249 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Minegishi, Genki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of the hepatic metabolism of triazolam in wild-type andCyp3a-knockout mice for understanding CYP3A-mediated metabolism inCYP3A-humanised mice in vivo |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.02.2020 | ||
500 | |a Date Revised 05.02.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a 1. To investigate cytochrome P450 3A (CYP3A)-mediated metabolism in vivo, plasma concentrations of triazolam (TRZ) are often monitored as a CYP3A marker in CYP3A-humanised mice. However, it has not been determined whether plasma concentrations of TRZ after intravenous administration can reflect hepatic CYP3A activity in CYP3A-humanised mice. 2. Firstly, we investigated the pharmacokinetics of TRZ in wild-type and Cyp3a-knockout (Cyp3a-KO) mice. Plasma concentration profiles of TRZ and α-hydroxy (OH) TRZ were very similar in wild-type and Cyp3a-KO mice. On the other hand, AUC of 4-OH TRZ in Cyp3a-KO mice was significantly lower than that in wild-type mice. Pregnenolone 16α-carbonitrile (PCN) decreased the areas under the plasma concentration-time curves (AUCs) of TRZ and α-OH TRZ in both groups. There was no significant effect of PCN on AUC of 4-OH TRZ in Cyp3a-KO mice. 3. Next, we verified that AUC of 4-OH TRZ in CYP3A-humanised mice was higher than that in Cyp3a-KO mice, although the difference was not significant. 4. In conclusion, plasma concentrations of 4-OH TRZ, but not those of TRZ and α-OH TRZ, might reflect hepatic CYP3A activity in mice in vivo. These results provide important insights for in vivo studies using a CYP3A-humanised model | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Video-Audio Media | |
650 | 4 | |a Cytochrome P450 3A | |
650 | 4 | |a drug-drug interaction | |
650 | 4 | |a hepatic metabolism | |
650 | 4 | |a humanised mouse | |
650 | 4 | |a induction | |
650 | 4 | |a pharmacokinetics | |
650 | 4 | |a triazolam | |
650 | 7 | |a cytochrome P-450 CYP2C subfamily |2 NLM | |
650 | 7 | |a Pregnenolone Carbonitrile |2 NLM | |
650 | 7 | |a 1434-54-4 |2 NLM | |
650 | 7 | |a Triazolam |2 NLM | |
650 | 7 | |a 1HM943223R |2 NLM | |
650 | 7 | |a Cytochrome P-450 Enzyme System |2 NLM | |
650 | 7 | |a 9035-51-2 |2 NLM | |
650 | 7 | |a CYP3A protein, human |2 NLM | |
650 | 7 | |a EC 1.14.14.1 |2 NLM | |
650 | 7 | |a CYP3A protein, mouse |2 NLM | |
650 | 7 | |a EC 1.14.14.1 |2 NLM | |
650 | 7 | |a Cytochrome P-450 CYP3A |2 NLM | |
650 | 7 | |a EC 1.14.14.1 |2 NLM | |
700 | 1 | |a Kazuki, Yasuhiro |e verfasserin |4 aut | |
700 | 1 | |a Yamasaki, Yuki |e verfasserin |4 aut | |
700 | 1 | |a Okuya, Fuka |e verfasserin |4 aut | |
700 | 1 | |a Akita, Hidetaka |e verfasserin |4 aut | |
700 | 1 | |a Oshimura, Mitsuo |e verfasserin |4 aut | |
700 | 1 | |a Kobayashi, Kaoru |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Xenobiotica; the fate of foreign compounds in biological systems |d 1971 |g 49(2019), 11 vom: 17. Nov., Seite 1303-1310 |w (DE-627)NLM000064742 |x 1366-5928 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2019 |g number:11 |g day:17 |g month:11 |g pages:1303-1310 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/00498254.2018.1560516 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 49 |j 2019 |e 11 |b 17 |c 11 |h 1303-1310 |